Literature DB >> 17085379

A study of women on long-term hormone replacement therapy and their attitude to suggested cessation.

E Horner1, J Fleming, J Studd.   

Abstract

OBJECTIVE: The study was undertaken to determine the effect of advice to discontinue hormone replacement therapy (HRT) on 100 women who were well established on treatment without side-effects.
METHOD: The study was retrospective from November 2003 to April 2004, in a single gynecological practice in London, UK. One hundred consecutive long-term estrogen and testosterone hormone implant users were assessed as to their knowledge of recent studies regarding risks of long-term HRT and whether they wished to discontinue hormones.
RESULTS: All women receiving estrogen and testosterone implants, for a mean duration of 17.65 years (range 10-28 years), felt well informed concerning the Women's Health Initiative Study and the Million Women Study but only three women were happy to discontinue. The reasons given for the continuation of therapy were that they felt well and their quality of life had greatly improved. The mean estradiol and testosterone levels were 921 pmol/l and 1.91 nmol/l, respectively.
CONCLUSIONS: The high rate of continuation of hormone treatment indicates that, despite the recent adverse publicity, these women feel well informed and were not willing to discontinue with their hormone therapy if they felt well. A regular discussion of the risks and benefits of HRT remains mandatory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085379     DOI: 10.1080/13697130601024629

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  4 in total

1.  Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension.

Authors:  Erin J Aiello Bowles; Melissa L Anderson; Susan D Reed; Katherine M Newton; E Dawn Fitzgibbons; Deborah Seger; Diana S M Buist
Journal:  J Womens Health (Larchmt)       Date:  2010-08       Impact factor: 2.681

2.  Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Steen Zabell Abildstrøm; Casper Haslund Jørgensen; Rikke Sørensen; Morten Lock Hansen; Tina Ken Schramm; Ellen Løkkegaard; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

Review 3.  Patient barriers to and enablers of deprescribing: a systematic review.

Authors:  Emily Reeve; Josephine To; Ivanka Hendrix; Sepehr Shakib; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

4.  Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Rikke Sørensen; Jesper Lindhardsen; Ole Ahlehoff; Charlotte Andersson; Steen Zabell Abildstrøm; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  BMJ       Date:  2012-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.